Tattoo-Associated Uveitis: What Primary Eye Care Needs to Know in 2026

• by Peter Cass, OD, Christopher Wolfe, OD, FAAO

• May 1, 2026

Immune-Mediated Inflammatory Diseases Following Pediatric Uveitis Diagnosis

• by Jay Jiyong Kwak, Seung Won Lee, Nang Kyeong Lee, Jin Yeong Kim, Christopher Seungkyu Lee, Suk Ho Byeon, Sung Soo Kim, Yong Joon Kim

• May 15, 2026

Vamikibart Shows Early Safety in Uveitic Macular Edema

Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven

• by Kerri Miller

• May 7, 2026

• 3 min

Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized

• by Sumit Sharma, Phoebe Lin, Allen Hu, Eric B. Suhler, Meike Pauly-Evers, William Holmes, Zeinab Barekati, Daniela Willen, Lachlan Macgregor, Laura Steeples, Zdenka Haskova, Derrick Feenstra, David Silverman, Benedicte Passemard, Sascha Fauser, Marina Mesquida

• May 1, 2026